Clinical Topics & News
Literature Review
Generic Glatiramer Acetate Remains Safe and Effective for Two Years
Generic glatiramer acetate remains effective and safe over two years of treatment for patients with relapsing-remitting multiple sclerosis (MS),...
News
2017 update to McDonald criteria loosens MS diagnosis somewhat
Changes to the 2010 McDonald multiple sclerosis diagnostic criteria aim to promote earlier diagnosis and discourage misdiagnosis.
News
Two MS diagnostic criteria found to have similar accuracy
Retrospective study of 2010 McDonald and 2016 MAGNIMS criteria indicates a need for increased specificity for MS diagnosis.
News
Rituximab may outperform some other first-line multiple sclerosis treatments
Real-world effectiveness study in Sweden found rituximab had lowest discontinuation rate of all disease-modifying treatments studied.
Literature Review
How Does Cladribine Compare With Other MS Therapies?
New data confirm cladribine’s efficacy as a treatment for relapsing-remitting multiple sclerosis (MS), according to results published online ahead...
Literature Review
Which Factors Predict Conversion From CIS to MS?
Age at onset, exposure to disease-modifying drugs (DMDs), disability at onset, MRI criteria, and oligoclonal bands affect the likelihood of...
Literature Review
How Does Gender Influence Perceived Health in Older People With MS?
Older men adapt more poorly to aging with multiple sclerosis (MS), compared with older women, according to research published in the July–August...
Literature Review
Are Bladder Dysfunction and Falls Related in MS?
Urinary urgency with incontinence is associated with recurrent falls in people with relapsing-remitting multiple sclerosis (MS) with mild to...
Literature Review
How Does Cognitive Demand Affect Mobility in MS?
Patients with multiple sclerosis (MS) with an Expanded Disability Status Scale (EDSS) score between 4 and 6 have significantly slower times on the...
News
Minocycline may delay conversion to MS
The results of a randomized, double-blind, placebo-controlled trial require confirmation in larger and longer trials.